Impact of FFR After Stenting: Useful or Mere Fun Fact?

Suboptimal fractional flow reserve (FFR) results after stenting only have a moderate impact on clinical hard points but might predict a much higher risk of reintervention.

Impacto del FFR post stent ¿dato útil o solo una curiosidad?

FFR has shown a huge impact on the decision-making process when it comes to revascularizing (or not) a lesion. Its impact after angioplasty has not been fully studied, particularly in the long term. We know the thresholds before angioplasty, but should there be target values after that procedure? If FFR does not improve as much as we expected after stenting, should it be optimized, somehow?

This large-scale study included all patients who underwent FFR-guided angioplasty.

FFR was measured immediately after angioplasty and then once the operator considered the outcome as acceptable and final. These results were only observational, since no action was taken based on them.

A suboptimal result was defined as final FFR <0.90. The final endpoint was a composite of cardiac death, infarction, and any revascularization after a 2-year follow-up.

With 1000 patients included and 1165 vessels analyzed, FFR after angioplasty was <0.9 in 440 vessels (37.8%). Almost 400 patients left the cath lab with at least one vessel whose FFR was suboptimal. This accounts for over a third of the procedures; its frequency is surprising. We should remember that no action was taken based on these results.


Read also: FREEDOM with FFR: Different Outcomes?


The analysis per patient did not show a significant association between FFR results after angioplasty and combined events after 2 years of follow-up (hazard ratio [HR]: 1.08, 95% confidence interval [CI]: 0.73 to 1.60; p = 0.707). Upon consideration of each event separately, no association was found either.

The analysis per vessel offered different results. FFR <0.9 after angioplasty was associated with almost twice as many target-vessel revascularizations (HR: 1.91; 95% CI: 1.06 to 3.44; p = 0.030) and a higher risk for thrombosis.

Conclusion

Suboptimal FFR after angioplasty had no significant impact on hard cardiovascular events, but it was associated with almost twice as many target-vessel revascularizations.

CIRCINTERVENTIONS-120-009681FREE

Original Title: Impact of Poststenting Fractional Flow Reserve on Long-Term Clinical Outcomes. The FFR-SEARCH Study.

Reference: Roberto Diletti et al. Circ Cardiovasc Interv. 2021;14:e009681. DOI: 10.1161/CIRCINTERVENTIONS.120.009681.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...